Giving millions of diabetics across the country an alternative to daily needle sticks, the Food and Drug Administration approved the first inhalable version of insulin Friday.

The drug, which will be marketed as Exubera, is made by Pfizer, Inc. It is the first new way to take insulin since the 1920s. The drug was developed in a joint agreement between Pfizer, Sanofi-Aventis and Nektar Therapeutics. The drug giant said it will be available to patients later this year

The U.S. Food and Drug Administration approved the first inhaled insulin treatment for diabetes on Friday.

The approval of Exubera provides an alternative for for type 1 and type 2 diabetes patients who want to avoid needles and injections, reports HealthDay News

A study conducted in Iceland concluded that a simple change in genetics could predispose almost 40 percent of the population to type-2 diabetes.

Researchers released results of the study Sunday. Kari Stefansson and his team of colleagues say that they are hoping their findings will help pave the way for better treatments and a possible cure

Howard Hughes Medical Institute researchers have discovered a molecular link between a high fat, Western-style diet, and the onset of type 2 diabetes.

The researchers also report that knocking out a single gene encoding the enzyme GnT-4a glycosyltransferase (GnT-4a ) disrupts insulin production

Scientists suggest they have found a reason why some shorter children perform less well at school.

University of Bristol researchers are linking low growth hormone levels with low IQ